Imagine a tiny, cheap chip that acts like a high-powered flashlight for germs. Instead of sending samples to a big lab and waiting days, this tool uses light-emitting chemical reactions to spot viruses or bacteria almost instantly. It's like having a professional medical lab shrunk down to the size of a handheld device.
Current pathogen detection often requires expensive lab equipment and long wait times. There is an urgent need for tools that are simultaneously reliable, fast, cheap, and portable to manage pandemics and endemic diseases.
A diagnostic platform consisting of Phage-Chips and NA-Chips integrated into microfluidic cartridges for detecting viruses, bacteria, and parasites.
If you are a device manufacturer dealing with slow lab turnaround times — this project developed a portable ECL-based sensor that provides fast and reliable tracking of infections. It uses a microfluidic cartridge to make testing simple and cheap.
If you are an NGO dealing with infectious diseases in developing countries — this project developed a cheap and simple detection approach. It is designed to be a ready-for-the-next-pandemic technology for millions of people.
If you are a biotech SME dealing with low sensitivity in rapid tests — this project developed signal amplification structures and Phage-Sandwich technology. This allows for the detection of whole pathogens with high affinity and selectivity.
Based on available project data, the specific price is not listed, but the objective explicitly defines the platform as being designed to be 'cheap' and 'simple' for use in developing countries.
The project has already moved toward scaling by fabricating first batches of 20 Phage-Chips and 20 NA-Chips with integrated microfluidic cartridges.
Based on available project data, specific patent numbers are not provided, but the project involves 3 industry partners and 3 SMEs, suggesting a structured transfer to industry.
The project objective describes the tool as 'fast', though the exact number of minutes or seconds is not specified in the provided data.
The technology is integrated into microfluidic cartridges, making it a portable device that can be used for fast testing and reliable tracking of infections.
The consortium is well-balanced for commercialization, featuring a 30% industry ratio with 3 SMEs and 3 industrial partners. With 10 partners across 4 countries (BE, CH, DE, IT), the project blends academic research from 4 universities and 2 research institutes with practical industrial application, reducing the gap between lab discovery and market entry.
Contact ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Contact us to explore licensing opportunities for the ECLIPSE microfluidic chip technology.
